Anti-infective Guidelines
By MUMS Health
Anti-infective Guidelines is a paid, offline-first antibiotic prescribing reference for family medicine and emergency room practitioners.
The App DNA
What makes this app unique?
It removes the dependency on internet connectivity for clinical decision support in hospital environments where network access is often unreliable.
For Family medicine practitioners and emergency room staff requiring evidence-based, offline-accessible antibiotic guidelines.
What does it look like?
Key features
Interactive logic flows for antibiotic prescription guidance; justifies the $17.99 price point.
Full content availability without internet; ensures reliability in hospital settings with poor connectivity.
Access to discounted physical viral info pads via the website; cross-sells physical products to increase customer lifetime value.
How much does it cost?
Paid model at $17.99 per download, with proceeds explicitly allocated to maintaining editorial independence.
Velocity
Dormant developmentopaqueShow more...
The app is currently in a zombie state, as the last recorded release occurred on May 4, 2026. Prior to this, the development history shows significant gaps, with no updates between 2019 and 2026. There is no evidence of active maintenance, feature development, or live operations. The lack of consistent release activity suggests the project is no longer being actively supported.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Anti-infective Guidelines
How's the Medical market?
Anti-infective Guidelines holds a niche position in the Medical category, relying on a one-time $17.99 purchase. Its lack of updates since 2019 leaves it vulnerable to rivals like Johns Hopkins Antibiotic Guide that provide monthly content updates.
Read the market outlookThe rivals identified
By MD Aware, LLC
Both apps target healthcare professionals requiring bedside clinical decision support, with both providing offline-first functionality for hospital environments with poor connectivity.
- MDCalc provides a library of 900+ clinical calculators, while Anti-infective Guidelines focuses on a static antibiotic reference.
- MDCalc includes CME tracking for professional development, a feature not present in Anti-infective Guidelines.
- MDCalc utilizes a free, ad-supported model, whereas Anti-infective Guidelines requires a $17.99 one-time purchase.
5 Minute Clinical Consult 5MCCContender
EMRA Antibiotic GuideContender
Johns Hopkins Antibiotic GuideContender
Quick Diagnosis & TreatmentContender
MobilEMContender
Pneumonia GuideContender
Concise Medicine HandbookContender
CDC Vaccine SchedulesContenderUnlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Anti-infective Guidelines
Where is it heading?
The medical reference market is consolidating around dynamic, evidence-based tools that provide real-time updates. Anti-infective Guidelines remains exposed due to its static content model, which will likely lead to further decline in user trust and market share.
- The lack of updates since 2019 creates a widening clinical relevance gap, which will accelerate user churn toward dynamic, updated competitors.
The SWOT
- Offline-first architecture ensures utility in hospital environments with poor connectivity
- Cross-selling physical viral info pads via the website provides a secondary revenue stream
Next best moves
Pivot to a subscription model because the current static content model fails to fund necessary clinical updates → increase content relevance
The counter-intuitive read
The app's static nature is a feature, not a bug…
Read the full takeFeature gaps
Real-time clinical guideline updates (available in Johns Hopkins Antibiotic Guide but absent here) +1
Since the last report: The intelligence report now benchmarks the app against specific clinical competitors and formalizes the clinical relevance gap in the SWOT analysis. While the product remains in a static state, the competitive positioning has been sharpened to highlight the trade-offs between static, offline-first tools and dynamic, cloud-connected alternatives.
Bottom line
Anti-infective Guidelines provides a reliable, offline-first reference, but the lack of updates since 2019 limits its clinical utility against rivals that provide current, evidence-based protocols.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated